Genzyme Transgenics, Quintiles deal

GZTC (Framingham, Mass.) sold its G.D.R.U. Ltd. subsidiary to QTRN for $9.5 million. G.D.R.U. (London) provides Phase I safety, pharmacokinetic and pharmacodynamic data. ...